Anika Therapeutics reported $132K in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acorda Therapeutics ACOR:US USD 187.69M 2.71M
Agenus AGEN:US USD 13.46M 241K
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
Clovis Oncology CLVS:US USD 660.38M 13.49M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Heron Therapeutics HRTX:US USD 149.23M 52K
Insmed INSM:US USD 807.82M 491K
Integra Lifesciences IART:US USD 1.54B 5.27M
Intrexon XON:US USD 82.07M 116.6M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Ligand Pharmaceuticals LGND:US USD 76.65M 38.38M
Merit Medical Systems MMSI:US USD 216.66M 29.35M
Peregrine Pharmaceuticals PPHM:US USD 142.31M 136K
Rigel Pharmaceuticals RIGL:US USD 39.47M 9.63M
Smith & Nephew PLC SN/:LN 2.89B 446M
Stryker SYK:US USD 12.75B 630M
Surmodics SRDX:US USD 10M 0
Veracyte VCYT:US USD 1.69M 46K
Zimmer Biomet Holdings Inc ZBH:US USD 5.71B 309.6M